How to Buy Septerna Stock
Septerna Inc
Septerna, Inc. , a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.
Septerna stock last closed at $28.62, down 2.88% from the previous day, and has increased 11.1% in one year. It has overperformed other stocks in the Biotechnology industry by 0.46 percentage points. Septerna stock is currently +586.33% from its 52-week low of $4.17, and -6.16% from its 52-week high of $30.50.
As of Dec 26, 2025, there are 44.77M shares of SEPN outstanding. The market capitalization of SEPN is $1.28B. In the last 24 hours, 118,000 SEPN shares were traded.
How to Buy Septerna Stock
Wondering how to invest in Septerna stock? Here's how.
- Figure out where to buy Septerna stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you choose where to buy Septerna stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Put funds into your investment account: Pick your method of payment and add your details.
- Analyze Septerna stock: The Septerna ticker symbol is SEPN. Is Septerna stock a good investment? Should you buy shares of SEPN? How do SEPN's underlying business fundamentals look? Do top analysts think Septerna is a good buy? Why has SEPN's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if SEPN is a good stock to buy).
- Place your SEPN trade: Decide if you will purchase SEPN shares at the current market price or use a limit order to buy SEPN shares at a specific price.
- Track your investment in SEPN: Create a watchlist to keep track of your position in Septerna shares.
Step 1: Figure out where to buy Septerna stock
You will need an online brokerage account to access the NASDAQ market and buy SEPN shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal info so you are able to invest in SEPN today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to start your new trading account.
- Send your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have finished signing up on the best stock app, your next step is to transfer the money for your investment:
Check out the video below to see the process of depositing funds into your new investment account.
Step 4: Analyze Septerna stock
After you have figured out the best place to buy Septerna stock, it's very important to research their stock before you buy, so you truly understand the risk as well as the opportunity.
Septerna quick stats
SEPN Fundamentals
WallStreetZen was created to help average investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SEPN's stock page.
What is the fair value of SEPN stock?
Investors use many financial metrics, analyses, models, and charts to gauge SEPN's intrinsic value.
Using relative valuations metrics:
- SEPN could be undervalued based on its P/E ratio of 2.08x, relative to Biotechnology industry P/E ratio of 146.24x
- SEPN could be undervalued based on its P/B ratio of 3.3x, relative to Biotechnology industry P/B ratio of 5.4x
You can do additional valuation research on SEPN's stock here.
A quick look at SEPN Financials
Passed Health Checks:
- There are more short-term assets than short-term liabilities on the SEPN balance sheet.
- SEPN's operating cash flow of $104.22M allows it to safely service it's debt of $24.11M.
- There are more short-term assets than long-term liabilities on the SEPN balance sheet.
Failed Health Checks:
- SEPN earnings of -$58.97M is not enough to cover its interest payments.
- SEPN profit margin has gone up by 17.57 percentage points in the past year, but the company is still unprofitable.
- SEPN has a relatively high debt to equity ratio of 0.56.
Is SEPN stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 6 sell side analysts who give recommendations on SEPN, the consensus analyst rating on SEPN is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they financial advice.
Latest SEPN Analyst Recommendations
Joshua Schimmer, a top 1% analyst from Cantor Fitzgerald reiterates SEPN with a strong buy rating and maintains their SEPN price target from $25.00 to $25.00, on Sep 5, 2025.
You can dive deeper into what analysts are saying on the Septerna stock forecast page.
SEPN Trading Indicators
How are SEPN Revenues/Earnings doing?
Last year, SEPN revenue was $22.05M. During the last one years, SEPN's revenue has increased by 2,147.2% per year. This was faster than the Biotechnology industry average of 44.67%.
You can analyze SEPN's earnings and revenue performance here.
Are SEPN executives and large shareholders buying or selling the stock?
Over the last year, insiders at SEPN have bought more shares than they have sold.
Daniel D. Long, SVP Drug Discovery of SEPN, was the latest SEPN insider to sell. They sold $63,224.56 worth of SEPN shares on Nov 10, 2025.
Dig into more about who owns SEPN stock here.
Does SEPN provide a stable income stream?
No, Septerna doesn't provide an income stream by paying out dividends.
SEPN Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Place your SEPN trade
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally the easiest way to buy. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a particular price limit, use a limit order.
Press the Open Trade button and eToro will place the order.
If you want additional assistance investing in stocks on eToro, click the helpful video below:
Step 6: Track your investment in SEPN
Now that you own some SEPN shares, you'll want to keep up with your new investment.
Put SEPN on a watchlist to get notified of the latest news about your SEPN stock.
SEPN Feed
How to Buy Stock in Septerna
To reiterate, here are the 6 steps to buy Septerna stock:
- Figure out where to buy Septerna stock
- Create your brokerage account
- Put funds into your investment account
- Analyze Septerna stock
- Place your SEPN trade
- Track your investment in SEPN
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Septerna, get started below.
Other Stock Buying Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.